Horizon Pharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference DEERFIELD, IL -- (Marketwired) -- 09/20/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 20th Annual NewsMakers in the Biotech Industry Conference on Friday, September 27th at 3:00 p.m. Eastern Time in New York, NY. Mr. Smith will provide an overview of the Company and its corporate activities. The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days. About Horizon Pharma Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com. Contacts Robert J. De Vaere Executive Vice President and Chief Financial Officer firstname.lastname@example.org Investors Kathy Galante Burns McClellan, Inc. 212-213-0006 email@example.com
Horizon Pharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference
Press spacebar to pause and continue. Press esc to stop.